Cytosolic β-amyloid deposition and supranuclear cataracts in lenses from people with Alzheimer's disease

Lancet

Volumn 361, Issue 9365, 2003, Pages 1258-1265

  Goldstein, Lee E ^a,b   Muffat, Julien A ^a,b,c   Cherny, Robert A ^e   Moir, Robert D ^a   Ericsson, Maria H ^d   Huang, Xudong ^a   Mavros, Christine ^e   Coccia, Jennifer A ^a   Faget, Kyle Y ^a   Fitch, Karlotta A ^a   Masters, Colin L ^e   Tanzi, Rudolph E ^a   Chylack Jr , Leo T ^b   Bush, Ashley I ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c UNIVERSITÉ PARIS SACLAY   (France)

^d HARVARD MEDICAL SCHOOL   (United States)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CRYSTALLIN; AMYLOID BETA PROTEIN; BRAIN PROTEIN; CONGO RED; LENS PROTEIN;

ALZHEIMER DISEASE; AQUEOUS HUMOR; ARTICLE; AUTOPSY; BIREFRINGENCE; BRAIN; CATARACT; CATARACT EXTRACTION; CEREBROSPINAL FLUID; CONTROLLED STUDY; CYTOPLASM; CYTOSOL; DISEASE ASSOCIATION; EYE; HUMAN; HUMAN TISSUE; IMMUNOGOLD ELECTRON MICROSCOPY; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LENS; LENS FIBER; MASS SPECTROMETRY; PATHOLOGY; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN BINDING; PROTEIN CONTENT; PROTEIN INTERACTION; SLIT LAMP; WESTERN BLOTTING;

EID: 0037433668     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(03)12981-9     Document Type: Article

References (30)

1. Kang J., Lemaire H.G., Unterbeck A., et al. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature. 325:1987;733-736.
2. Tanzi R.E., Bertram L. New frontiers in Alzheimer's disease genetics. Neuron. 32:2001;181-184.
3. Butterfield D.A., Lauderback C.M. Lipid peroxidation and protein oxidation in Alzheimer's disease brain: potential causes and consequences involving amyloid beta-peptide-associated free radical oxidative stress. Free. Radic. Biol. Med. 32:2002;1050-1060.
4. Hanson S.R., Hasan A., Smith D.L., Smith J.B. The major in vivo modifications of the human water-insoluble lens crystallins are disulfide bonds, deamidation, methionine oxidation and backbone cleavage. Exp. Eye. Res. 71:2000;195-207.
5. Spector A. Oxidation and cataract. Ciba. Found. Symp. 106:1984;48-64.
6. Lowe R.F. The eyes in mongolism. Br. J. Ophthalmol. 33:1949;131-174.
7. Holton J.L., Lashley T., Ghiso J., et al. Familial Danish dementia: a novel form of cerebral amyloidosis associated with deposition of both amyloid-Dan and amyloid-beta. J. Neuropathol. Exp. Neurol. 61:2002;254-267.
8. Frederikse P.H., Garland D., Zigler J.S.J., Piatigorsky J. Oxidative stress increases production of beta-amyloid precursor protein and beta-amyloid (Aβ) in mammalian lenses, and Aβ has toxic effects on lens epithelial cells. J. Biol. Chem. 271:1996;10169-10174.
9. Horwitz J. The function of alpha-crystallin in vision. Semin. Cell. Dev. Biol. 11:2000;53-60.
10. Lowe J., Errington D.R., Lennox G., et al. Ballooned neurons in several neurodegenerative diseases and stroke contain αB crystallin. Neuropathol. Appl. Neurobiol. 18:1992;341-350.
11. Stege G.J., Renkawek K., Overkamp P.S., et al. The molecular chaperone alphaB-crystallin enhances amyloid beta neurotoxicity. Biochem. Biophys. Res. Commun. 262:1999;152-156.
12. Liang J.J. Interaction between beta-amyloid and lens alphaB-crystallin. FEBS. Lett. 484:2000;98-101.
13. Fonte V., Kapulkin V., Taft A., Fluet A., Friedman D., Link C.D. Interaction of intracellular beta amyloid peptide with chaperone proteins. Proc. Natl. Acad. Sci. U. S. A. 99:2002;9439-9444.
14. Harding J.J. Alzheimer disease and cataract: common threads. Alz. Dis. Assoc. Dis. 11:1997;123.
15. Bush A.I., Goldstein L.E. Specific metal-catalysed protein oxidation reactions in chronic degenerative disorders of ageing: focus on Alzheimer's disease and age-related cataracts. Novartis. Found. Symp. 235:2001;26-38.
16. Mirra S.S., Heyman A., McKeel D., et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD), part II: standardization of the neuropathologic assessment of Alzheimer's disease. Neurology. 41:1991;479-486.
17. Chylack L.T. Jr. Classification of human cataractous change by the American Cooperative Cataract Research Group method. Ciba. Found. Symp. 106:1984;3-24.
18. Moir R.D., Lynch T., Bush A.I., et al. Relative increase in Alzheimer's disease of soluble forms of cerebral Abeta amyloid protein precursor containing the Kunitz protease inhibitory domain. J. Biol. Chem. 273:1998;5013-5019.
19. Cherny R.A., Legg J.T., McLean C.A., et al. Aqueous dissolution of Alzheimer's disease Abeta amyloid deposits by biometal depletion. J. Biol. Chem. 274:1999;23223-23228.
20. Griffiths G. Fine structure immunocytochemistry. 1993;Springer Verlag, Heidelberg.
21. Moir R.D., Atwood C.S., Romano D.M., et al. Differential effects of apolipoprotein E isoforms on metal-induced aggregation of Aβ using physiological concentrations. Biochem. 38:1999;4595-4603.
22. Chylack L.T. Jr, White O., Tung W.H. Classification of human senile cataractous change by the American Cooperative Cataract Research Group (CCRG) method: II, staged simplification of cataract classification. Invest. Ophthalmol. Vis. Sci. 25:1984;166-173.
23. Hartley D.M., Walsh D.M., Ye C.P., et al. Protofibrillar intermediates of amyloid beta-protein induce acute electrophysiological changes and progressive neurotoxicity in cortical neurons. J. Neurosci. 19:1999;8876-8884.
24. McLean C.A., Cherny R.A., Fraser F.W., et al. Soluble pool of Aβ amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease. Ann. Neurol. 46:1999;860-866.
25. Skovronsky D.M., Doms R.W., Lee V.M. Detection of a novel intraneuronal pool of insoluble amyloid beta protein that accumulates with time in culture. J. Cell. Biol. 141:1998;1031-1039.
26. Gouras G.K., Tsai J., Naslund J., et al. Intraneuronal Aβ42 accumulation in human brain. Am. J. Pathol. 156:2000;15-20.
27. Glabe C. Intracellular mechanisms of amyloid accumulation and pathogenesis in Alzheimer's disease. J. Mol. Neurosci. 17:2001;137-145.
28. Joachim C.L., Mori H., Selkoe D.J. Amyloid beta-protein deposition in tissues other than brain. Nature. 341:1989;226-230.
29. Benedek G.B. Theory of transparency of the eye. Applied. Optics. 10:1971;459-473.
30. Vaezy S., Clark J.I. A quantitative analysis of transparency in the human sclera and cornea using Fourier methods. J. Microsc. 163:1991;85-94.